Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | GRN-1201 |
Trade Name | |
Synonyms | |
Drug Descriptions |
GRN-1201 is a peptide cancer vaccine that targets four tumor associated antigens restricted to HLA-A2 to increase the activation of tumor-specific T cells (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C128489 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
GRN-1201 | GRN-1201 | 0 | 0 |
GRN-1201 + Pembrolizumab | GRN-1201 Pembrolizumab | 0 | 1 |